CJC-1295 DAC - Generic Peptides

Buy CJC-1295 DAC 2, 5 and 10 mg vials by Generic Peptides at XSteroids. CJC-1295 DAC pairs a GHRH analogue with a drug affinity complex that ties it to albumin and stretches its action across days. It reaches you as lyophilized powder packed for laboratory work. Here you will find the peptide itself, what the DAC does to its behavior, what the clinical program turned up, how much water each vial takes and the storage and legal framework.

CJC-1295 holds no license anywhere and carries no ATC code. The powder described below is bench material, and each quantity quoted is a laboratory figure rather than an approved human dose.

What CJC-1295 DAC by Generic Peptides Is and What You Are Buying

CJC-1295 is a modified form of GHRH(1-29), the first 29 amino acids of growth hormone releasing hormone, with the sequence adjusted for stability and a small chemical tag attached. That tag is the DAC, the drug affinity complex, and its job is to bind the peptide to plasma albumin. The molecular mass is about 3647.25 g/mol, and the route used in research is subcutaneous injection.

Your order is a single glass vial, white lyophilized powder inside, at 2 mg, 5 mg or 10 mg. Water for mixing is left out of the pack. No excipient list comes with these vials and no outside potency test is on record, so the page reports only what the supplier documents.

How CJC-1295 DAC Works in the Body

CJC-1295 does not deliver growth hormone itself. It is a GHRH analogue, so it binds the GHRH receptor on pituitary somatotroph cells and prompts the gland to release its own growth hormone. Because the DAC anchors the peptide to albumin, the peptide is not cleared quickly: the albumin complex stays in circulation and keeps presenting the signal. The published pharmacokinetic estimate for the half-life in humans is about 6 to 8 days, with some reviews giving a range of 5.8 to 8.1 days.

The downstream consequence is a long, flat elevation rather than the sharp pulse the body normally produces. A single injection raised plasma growth hormone 2 to 10 fold for 6 days and more, and IGF-1 rose 0.5 to 3 fold for 9 to 11 days in the reported data. With repeated dosing, IGF-1 stayed elevated for up to 28 days. That is the central trade-off of the DAC version: fewer injections and a sustained signal, at the cost of the natural pulsatile pattern. The peptide carries no ATC code and is not a registered medicine anywhere, which is why the vials on this page are sold only for laboratory work.

What to Expect from CJC-1295 DAC Research

Clinical development reached phase II for lipodystrophy and growth hormone deficiency, and the program was stopped in 2006 after a participant died during the lipodystrophy study. There are therefore no long-term human safety data for this peptide, and this page will not manufacture any.

What the studies did show is a measurable hormonal effect: the growth hormone and IGF-1 elevations described above, on a schedule that required dosing roughly once or twice a week rather than daily. What they did not show is a clinical benefit that survived to approval. Claims about fat loss, recovery or sleep are unsupported by the trial record. The markers to follow in laboratory work are IGF-1 and growth hormone; those are the numbers the studies used.

Mixing CJC-1295 DAC Vials: 2, 5 and 10 mg

Work the strength out before measuring anything. Take the powder mass and divide it by the millilitres of water added; that figure is mg per ml. Each unit on a U-100 insulin syringe is 0.01 ml, so 0.1 ml is 10 units. Add 1 ml to the 2 mg vial for 2 mg per ml, where a 0.1 ml draw carries 200 mcg. Add 2 ml to the 5 mg vial for 2.5 mg per ml, where that same draw carries 250 mcg. Add 2 ml to the 10 mg vial for 5 mg per ml, where 0.1 ml carries 500 mcg.

Because the peptide lasts for days in circulation, laboratory schedules built around it are sparse compared with the short-acting version. Write the concentration on the vial before refrigerating, and mix only what a schedule can use inside the stability window. Record the concentration and the mixing date on the vial as well, because a long-acting peptide makes it easy to lose track of which solution is which.

Stacking CJC-1295 DAC With Other Generic Peptides

The usual pairing is a GHRH analogue with a ghrelin receptor secretagogue: the two hit different receptors, and they are studied together for a larger growth hormone response. The short secretagogues are GHRP-2 (5 and 10 mg) and GHRP-6 (5 and 10 mg), while Ipamorelin 2, 5 and 10 mg is the more selective option.

Within the GHRH family, CJC-1295 (no DAC) 2, 5 and 10 mg is the short-acting alternative, Sermorelin 2, 5 and 10 mg is the older analogue, and Tesamorelin 2, 5 and 10 mg is the version studied for visceral fat. For the direct hormone route by comparison, see Somatropin 100 to 200 IU. None of these combinations is approved.

Recovery Markers After CJC-1295 DAC Research

CJC-1295 acts upstream of the testosterone axis; natural production is not suppressed, so no post-cycle therapy is called for. The laboratory markers the studies relied on are IGF-1 and growth hormone, with IGF-1 being the more stable readout because it moves more slowly. Because the DAC version holds IGF-1 up for weeks after the last dose, a washout period matters when a schedule is being compared against baseline.

CJC-1295 DAC Side Effects and Legal Status

Reported effects in the peptide literature include injection site reactions, water retention, joint aches and changes in glucose handling, all consistent with elevated growth hormone and IGF-1. The phase II halt means the long-term safety picture is genuinely unknown. Growth hormone releasing factors and secretagogues fall under WADA class S2 and are prohibited at all times, and CJC-1295 has no approved medical use anywhere.

Storage and Handling of CJC-1295 DAC

Dry powder is held at 2 to 8 C, shielded from light, and never frozen. After water is added the vial is refrigerated at 2 to 8 C and used inside 28 to 30 days. A solution that turns cloudy or carries particles is discarded.

Why Buy CJC-1295 DAC Vials from XSteroids?

At XSteroids, CJC-1295 DAC is sold through the Generic Peptides brand catalog. All three strengths share a page, the checkout is encrypted, parcels arrive in the US in 3 to 6 days and abroad in 12 to 26 days. Further cards cover the ghrelin secretagogues and the direct hormone route.